Tech Company Financing Transactions

Pearl Therapeutics Funding Round

Pearl Therapeutics secured a $69 million Series C financing round on 10/19/2010. Investors included Vatera Healthcare Partners, 5AM Ventures and Clarus.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

200 Saginaw Drive
Redwood City, CA 94063
USA

Phone

(650) 305-2600

Website

www.pearltherapeutics.com

Email Address

[email protected]

Overview

Pearl Therapeutics is focused on developing a pipeline of novel andsuperior products for chronic respiratory disorders, providing patientswith advanced therapeutic options in familiar and well accepted dosageforms. The company has licensed advanced particle technology from NektarTherapeutics (Nasdaq: NKTR) for developing a series of products in selectedtherapeutic fields.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Charles Bramlage

        

Chief Medical Officer

Colin Reisner

        

Chief Scientific Officer

Sarvajna Dwivedi

        

VP - Bus. Development

Lyn Baranowski

        

VP - Finance

William Picht

        

VP - Product Management

Robert Schultz

        

VP - Regulatory Affairs

Michael Golden

        

Browse more venture capital transactions:

Prev: 10/19/2010: Buddy Media venture capital transaction
Next: 10/20/2010: Solar Components venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary